These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23436697)
1. Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor. Kuijjer ML; Hogendoorn PC; Cleton-Jansen AM Int J Cancer; 2013 Dec; 133(11):2512-21. PubMed ID: 23436697 [TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Buddingh EP; Kuijjer ML; Duim RA; Bürger H; Agelopoulos K; Myklebost O; Serra M; Mertens F; Hogendoorn PC; Lankester AC; Cleton-Jansen AM Clin Cancer Res; 2011 Apr; 17(8):2110-9. PubMed ID: 21372215 [TBL] [Abstract][Full Text] [Related]
3. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH. Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480 [TBL] [Abstract][Full Text] [Related]
4. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Kuijjer ML; Rydbeck H; Kresse SH; Buddingh EP; Lid AB; Roelofs H; Bürger H; Myklebost O; Hogendoorn PC; Meza-Zepeda LA; Cleton-Jansen AM Genes Chromosomes Cancer; 2012 Jul; 51(7):696-706. PubMed ID: 22454324 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide transcriptome profile of the human osteosarcoma Sa OS and U-2 OS cell lines. Trougakos IP; Chondrogianni N; Amarantos I; Blake J; Schwager C; Wirkner U; Ansorge W; Gonos ES Cancer Genet Cytogenet; 2010 Jan; 196(2):109-18. PubMed ID: 20082845 [TBL] [Abstract][Full Text] [Related]
6. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384 [TBL] [Abstract][Full Text] [Related]
7. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556 [TBL] [Abstract][Full Text] [Related]
8. Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes. Muff R; Rath P; Ram Kumar RM; Husmann K; Born W; Baudis M; Fuchs B PLoS One; 2015; 10(5):e0125611. PubMed ID: 25992885 [TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells. Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304 [TBL] [Abstract][Full Text] [Related]
11. Genomics and the Immune Landscape of Osteosarcoma. Wu CC; Livingston JA Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232 [TBL] [Abstract][Full Text] [Related]
12. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine. Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912 [TBL] [Abstract][Full Text] [Related]
13. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study. Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448 [TBL] [Abstract][Full Text] [Related]
14. Microarray expression profile of long noncoding RNAs in human osteosarcoma. Li JP; Liu LH; Li J; Chen Y; Jiang XW; Ouyang YR; Liu YQ; Zhong H; Li H; Xiao T Biochem Biophys Res Commun; 2013 Apr; 433(2):200-6. PubMed ID: 23466354 [TBL] [Abstract][Full Text] [Related]
15. Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy. Zhao J; Dean DC; Hornicek FJ; Yu X; Duan Z Cancer Lett; 2020 Apr; 474():158-167. PubMed ID: 31987920 [TBL] [Abstract][Full Text] [Related]
16. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Hattinger CM; Tarkkanen M; Benini S; Pasello M; Stoico G; Bacchini P; Knuutila S; Scotlandi K; Picci P; Serra M Eur J Cell Biol; 2004 Sep; 83(9):483-91. PubMed ID: 15540465 [TBL] [Abstract][Full Text] [Related]
18. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Mori K; Berreur M; Blanchard F; Chevalier C; Guisle-Marsollier I; Masson M; Rédini F; Heymann D Oncol Rep; 2007 Dec; 18(6):1365-71. PubMed ID: 17982618 [TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848 [TBL] [Abstract][Full Text] [Related]
20. Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Folio C; Zalacain M; Zandueta C; Ormazábal C; Sierrasesúmaga L; San Julián M; de las Rivas J; Toledo G; Lecanda F; Patiño-García A Cancer Biomark; 2011-2012; 10(1):35-41. PubMed ID: 22297550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]